![Fabio Chianelli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabio Chianelli
Directeur Général chez PHARMATHER HOLDINGS LTD.
Fortune : 3 M $ au 31/05/2024
Postes actifs de Fabio Chianelli
Sociétés | Poste | Début | Fin |
---|---|---|---|
PHARMATHER HOLDINGS LTD. | Directeur Général | 01/01/2020 | - |
Président | 01/01/2020 | - | |
DIAGNAMED HOLDINGS CORP. | Président | - | - |
Directeur Général | 11/08/2021 | - | |
Directeur/Membre du Conseil | 11/08/2021 | - | |
President | 11/08/2021 | - | |
Fabiotech, Inc.
![]() Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Corporate Officer/Principal | - | - |
Revive Therapeutics, Inc.
![]() Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Fondateur | - | - |
President | - | - | |
Pharmather, Inc.
![]() Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Directeur Général | - | - |
Historique de carrière de Fabio Chianelli
Anciens postes connus de Fabio Chianelli
Sociétés | Poste | Début | Fin |
---|---|---|---|
REVIVE THERAPEUTICS LTD. | Directeur/Membre du Conseil | 27/03/2012 | 18/12/2019 |
Directeur Général | 27/03/2012 | 05/07/2016 | |
Fondateur | 27/03/2012 | 18/12/2019 | |
President | 05/07/2016 | 18/12/2019 | |
TITAN MEDICAL INC. | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
Conseiller Juridique Général | - | - |
Formation de Fabio Chianelli
Toronto Metropolitan University of | Undergraduate Degree |
Statistiques
Internationale
Canada | 9 |
Opérationnelle
Chief Executive Officer | 4 |
President | 3 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
TITAN MEDICAL INC. | Health Technology |
REVIVE THERAPEUTICS LTD. | Health Technology |
PHARMATHER HOLDINGS LTD. | Health Technology |
DIAGNAMED HOLDINGS CORP. | Health Technology |
Entreprise privées | 3 |
---|---|
Fabiotech, Inc.
![]() Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Commercial Services |
Revive Therapeutics, Inc.
![]() Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Health Technology |
Pharmather, Inc.
![]() Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Health Technology |
- Bourse
- Insiders
- Fabio Chianelli
- Expérience